Laurie D J, Seeburg P H
Zentrum für Molekulare Biologie, Universität Heidelberg, Germany.
Eur J Pharmacol. 1994 Aug 16;268(3):335-45. doi: 10.1016/0922-4106(94)90058-2.
The ligand preferences of recombinant NR1 homomeric and NR1-NR2 heteromeric NMDA receptors were examined by homogenate binding assay. The binding affinities for most ligands were similar to those reported for native NMDA receptors. The order of affinity for [3H]glutamate was NR1-NR2B > NR1-NR2A approximately NR1-NR2D > NR1-NR2C > NR1. NMDA had approximately equal affinity for all heteromeric types (Ki approximately 5 microM), but the competitive antagonists CGS 19755 (cis-4-(phosphonomethyl)piperidine-2-carboxylic acid) and CGP 39653 (D,L-(E)-2-amino-4-propyl-5-phosphono-3-pentenoic acid) displayed the affinity order NR1-NR2A > NR1-NR2B > NR1-NR2D > NR1-NR2C. Binding of [3H]CGP 39653 could only be detected at the NR1-NR2A receptor type (Kd approximately 6 nM). The glycine site antagonist [3H]5,7-dichlorokynurenate bound with good affinity to all recombinant receptors (Kd approximately 50-100 nM), while glycine exhibited an affinity order of NR1-NR2C >> NR1 = NR1-NR2B = NR1-NR2D > NR1-NR2A. The channel-site ligand [3H]MK 801 ((+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate) showed the affinity ranking NR1-NR2A = NR1-NR2B >> NR1 > NR1-NR2C = NR1-NR2D. Thus the ligand binding affinities of recombinant NMDA receptors is dependent on their subunit composition. The NR1-NR2A, NR1-NR2B, NR1-NR2C and NR1-NR2D receptors may account for the antagonist-preferring, agonist-preferring, cerebellar, and medial thalamic subtypes of native NMDA receptors, respectively.
通过匀浆结合试验检测了重组NR1同聚体和NR1-NR2异聚体NMDA受体的配体偏好性。大多数配体的结合亲和力与天然NMDA受体的报道相似。对[3H]谷氨酸的亲和力顺序为NR1-NR2B>NR1-NR2A≈NR1-NR2D>NR1-NR2C>NR1。NMDA对所有异聚体类型的亲和力大致相等(Ki约为5 μM),但竞争性拮抗剂CGS 19755(顺式-4-(膦酰甲基)哌啶-2-羧酸)和CGP 39653(D,L-(E)-2-氨基-4-丙基-5-膦酰基-3-戊烯酸)的亲和力顺序为NR1-NR2A>NR1-NR2B>NR1-NR2D>NR1-NR2C。仅在NR1-NR2A受体类型中可检测到[3H]CGP 39653的结合(Kd约为6 nM)。甘氨酸位点拮抗剂[3H]5,7-二氯犬尿氨酸与所有重组受体具有良好的亲和力结合(Kd约为50-100 nM),而甘氨酸的亲和力顺序为NR1-NR2C>>NR1 = NR1-NR2B = NR1-NR2D>NR1-NR2A。通道位点配体[3H]MK 801((+)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺马来酸氢盐)的亲和力排名为NR1-NR2A = NR1-NR2B>>NR1>NR1-NR2C = NR1-NR2D。因此,重组NMDA受体的配体结合亲和力取决于其亚基组成。NR1-NR2A、NR1-NR2B、NR1-NR2C和NR1-NR2D受体可能分别对应于天然NMDA受体的拮抗剂偏好型、激动剂偏好型、小脑型和内侧丘脑亚型。